Acorda reports net income of $12.

‘We are gratified by the responses from patients and doctors, and so are proud that AMPYRA is providing exclusive benefits to people with MS.6 million. Acorda began delivery AMPYRA to specialty pharmacies on March 1, 2010 and recognized gross sales of $3.4 million in the first quarter and $29.7 million in the next quarter. Gross sales of AMPYRA are known pursuing shipment of the product from the Company’s distribution service to its network of specialty pharmacies.Most patients had several payer, including Medicare, Medicaid, private insurance, Medicare products and Medicare replacement plans. Analysis was limited by Caucasians and African-Americans because there were too little Hispanic and Asian recipients allowing meaningful comparisons. The experts found that an increased proportion of patients with private insurance, in accordance with those without personal insurance, received LKT – 22 % versus 7.6 %.